{
    "Trade/Device Name(s)": [
        "HemosIL D-Dimer HS"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K070927",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050544",
        "K040882"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DAP"
    ],
    "Summary Letter Date": "September 17, 2007",
    "Summary Letter Received Date": "April 3, 2007",
    "Submission Date": "March 30, 2007",
    "Regulation Number(s)": [
        "21 CFR 864.7320"
    ],
    "Regulation Name(s)": [
        "Fibrinogen/Fibrin Degradation Product Assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "D-Dimer"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP"
    ],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoassay",
        "Turbidimetric immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Turbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL D-Dimer HS automated latex enhanced immunoassay for quantitative D-Dimer measurement in citrated plasma to exclude venous thromboembolism.",
    "Indications for Use Summary": "Automated latex enhanced immunoassay for quantitative determination of D-Dimer in human citrated plasma on ACL TOP, used with a clinical pretest probability model to exclude venous thromboembolism (DVT and PE) in outpatients.",
    "fda_folder": "Hematology"
}